HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.03 | 0.02 | -0.00 |
| FCF Yield | -27,678.70% | -48.05% | -40.89% | -51.36% |
| EV / EBITDA | 0.51 | -1.75 | -3.08 | -1.54 |
| Quality | ||||
| ROIC | -40.99% | -36.83% | -60.19% | -49,677.15% |
| Gross Margin | 58.33% | 60.00% | 56.78% | 0.00% |
| Cash Conversion Ratio | 0.99 | 0.95 | 0.76 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | -22.20% | -89.33% | -90.55% | -100.00% |
| Free Cash Flow Growth | -120,016.61% | -22.25% | 2.28% | 25.29% |
| Safety | ||||
| Net Debt / EBITDA | 0.52 | 0.46 | -1.00 | -0.17 |
| Interest Coverage | 7.42 | -10.20 | -10.62 | -13,213.24 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -0.10 |
| Cash Conversion Cycle | 30,347.77 | 43,375.50 | 15,964.76 | -328.32 |